As an endogenous inhibitor of glucose-stimulated insulin secretion (GSIS), PGE2 plays an important role in type 2 diabetes mellitus (T2DM) (Carboneau et al., 2017). This evidence concerns the gene INS and type 2 diabetes mellitus.